At Charco Neurotech we have been fortunate enough to have the support of some bright minds. Dr David Galloway, a retired physician specialising in acute medicine and clinical pharmacology, is one of our clinical advisors. We caught up with him to discuss the science behind the CUE1
“How can we trust that we’ll succeed if our own CEO is shaking?” Whilst reading one person’s feedback from a presentation he had just delivered in the UK, Gary Shaughnessy, ex-CEO of EMEA of insurance company Zurich, and current Chair of Parkinson’s UK, came to comprehend what Parkinson’s really meant for him.
The second round of user testing has now been completed and we are very happy to announce that we have now published our report from our collaboration with Austrian insole sensor company Stapp one.
Speak to someone with Parkinson’s and they’ll be able to give you a long list of frustrations arising from where their symptoms have affected their everyday life.
When Florencia Cerruti was 47 years old, she was at the peak of her career. She worked at the Presidency of the Republic in Uruguay, in the highest professional position that one can achieve, following her master’s degree in nutrition.
Like many of the people we have had the great pleasure of speaking with, the delivery of Mark’s Parkinson’s diagnosis was blunt. His GP initially told him he was far too young to have Parkinson’s. He went on to see a specialist in what felt like a consultation lasting only a few minutes.
Our journey to a viable product began with a wonderful lady named Ruth and an invite to a Parkinson’s UK Peterborough branch
coffee morning. It was at this coffee morning at the beginning of 2019 that we met a number of people with Parkinson’s who were to go on to give kindly and generously of their time and energy.
As most areas in the UK ease out of lockdown, and others enter into it again, finding a ‘new normal’ can be stressful and challenging, particularly for those with Parkinson’s. Following a ‘Life After Lockdown’ webinar with Parkinson’s Concierge,